Zoetis | ZTS - Pre Tax Profit


Zoetis reported $761M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Align Technology USD 148.89M 27.71M Mar/2026
Bayer EUR -3.37B 2.21B Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Charles River Laboratories USD -294.1M 464.13M Dec/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Dentsply International USD -42M 105M Mar/2026
Eli Lilly USD 8.27B 1.03B Dec/2025
Henry Schein USD 150M 17M Mar/2026
Idexx Laboratories USD 355.44M 48.46M Mar/2026
Illumina USD 157M 220M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
J&J USD 7.82B 2.86B Mar/2026
Laboratory Of America USD 8.73B 8.54B Mar/2026
Merck USD 3.42B 3.32B Dec/2025
Neogen USD 28M 15.81M Sep/2025
Pacira USD 571K 8.95M Dec/2025
Perrigo USD -1.33B 1.35B Dec/2025
Pfizer USD 5.18B 6.82B Mar/2026
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Sanofi EUR -1.16B 5.5B Dec/2025
Sanofi EUR 2B 3.16B Mar/2026
Zoetis USD 761M 126M Dec/2025